PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Agency Insight
Putting the M Back in M&A
Joe Panetta, president and CEO of BIOCOM, discusses an emerging model of M&As in which human and IP assets are valued and biotech brings expertise to Big Pharma as venture capitalist funding dwindles and patent cliffs loom large.
Pharm Exec: Can you tell me about how small biotech and specialty companies have started switching from relying [...]
The HCR Taxman Cometh
By Tom Norton
As the country struggles with the current economic malaise, and the pharmaceutical industry enters into yet another difficult quarter of “trying to make the numbers,” one matter that I doubt many Rx execs are thinking about today is the HCR Taxman. That’s too bad. They probably should. That’s because he’s coming for the [...]
Also posted in Advertising, Biotech, Corporate Responsibility, Strategy, compliance Comments closed
Doing More With Less: A Leadership Perspective
Steven Blum, Director of Health Economics at Forest Laboratories and one of Pharm Exec’s 2011 Emerging Pharma leaders, recently spoke with Associate Editor Jennifer Ringler on building leadership and team rapport in today’s lean organization.
Also posted in Corporate Responsibility, leadership Tagged Emerging Pharma Leaders, Forest Laboratories, leadership, lean management, Steven Blum, Strategy 2 Comments
Mining Data to Gain a Competitive Edge
When gauging influence in oncology prescribing, membership in the “club” still counts
As the cancer therapeutics space grows more crowded, the task of identifying and building productive relationships with “key influencers” has become vital to a successful launch strategy. Like everything else in oncology, performing that task is harder today. What was once an inbred club [...]
Tasty Asian Acquisition for Publicis